There are no adequate and well-controlled studies of irinotecan in pregnant women. If the drug is used during pregnancy, or if the patient becomes pregnant while receiving this drug, the patient should be appraised of the potential hazard to the foetus. Women of child bearing potential should be advised to avoid becoming pregnant while receiving the treatment with irinotecan.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
